Capital Fund Management (CFM)
GPCR icon

Capital Fund Management (CFM)’s Structure Therapeutics GPCR Stock Holding History

Capital Fund Management (CFM)’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Buy
+32,436
New +$2.22M 0.01% 1486
2025
Q3 		– Sell
-14,350
Closed -$298K – 2546
2025
Q2 		$298K Sell
14,350
-65,306
-82% -$1.44M ﹤0.01% 2274
2025
Q1 		$1.38M Buy
79,656
+12,521
+19% +$307K ﹤0.01% 1553
2024
Q4 		$1.82M Buy
67,135
+17,007
+34% +$603K ﹤0.01% 1526
2024
Q3 		$2.2M Buy
+50,128
New +$1.94M 0.01% 1389

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Capital Fund Management (CFM)'s GPCR Position: Q1 2026 in Review

Capital Fund Management (CFM) opened a new position in Structure Therapeutics (GPCR) in Q1 2026: 32,436 shares worth $1.56M. The stake represents 0.01% of the portfolio and ranks #1486 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in GPCR as recently as Q2 2025.

Capital Fund Management (CFM) first reported a position in GPCR in Q3 2024 and has held it in 5 quarters since. The position peaked at $2.2M in Q3 2024. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Capital Fund Management (CFM) held 32,436 shares of Structure Therapeutics worth $1.56M as of Q1 2026.
  • Structure Therapeutics was a new Capital Fund Management (CFM) position in Q1 2026.
  • Structure Therapeutics made up 0.01% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #1486 holding.
  • Capital Fund Management (CFM) first reported a position in Structure Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • Capital Fund Management (CFM)'s Structure Therapeutics position peaked at $2.2M in Q3 2024.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.